Read your latest personalised notifications
Sign in
No account yet? Start here
Don't miss out
Ok, got it
News and opinion on the latest ESC Clinical Practice Guidelines
1.Preamble 2.Introduction 2.1 Definition of acute myocardial infarction 2.2 Epidemiology of ST-segment elevation myocardial infarction 3.What is new in the 2017 version? 4.Emergency care 4.1 Initial diagnosis 4.2 Relief of pain, breathlessness, and anxiety 4.3 Cardiac arrest 4.4 Prehospital logistics of care 5.Reperfusion therapy 5.1 Selection of reperfusion strategies 5.2 Primary percutaneous coronary intervention and adjunctive therapy 5.3 Fibrinolysis and pharmaco invasive strategy 5.4 Coronary artery bypass graft surgery 6.Management during hospitalization and at discharge 6.1 Coronary care unit/intensive coronary care unit 6.2 Monitoring 6.3 Ambulation 6.4 Length of stay 6.5 Special patient subsets 6.6. Risk assessment 7.Long-term therapies for ST-segment elevation myocardial infarction 7.1 Lifestyle interventions and risk factor control 7.2 Antithrombotic therapy 7.3 Beta-blockers 7.4 Lipid-lowering therapy 7.5 Nitrates 7.6 Calcium antagonists 7.7 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers 7.8 Mineralocorticoid/aldosterone receptor antagonists 8.Complications following ST-segment elevation myocardial infarction 8.1 Myocardial dysfunction 8.2 Heart failure 8.3 Management of arrhythmias and conduction disturbances in the acute phase 8.4 Mechanical complications 8.5 Pericarditis 9.Myocardial infarction with non-obstructive coronary arteries (MINOCA) 10.Assessment of quality of care 11.Gaps in the evidence and areas for future research 12.Key Messages 13.Evidenced-based “To do and not to do” messages from the Guidelines 14.Web addenda 15.Appendix 16.References
Our mission: To reduce the burden of cardiovascular disease
